Management of COPD With Cardiovascular Risk in Asia: A Review by the Asian Pacific Society of Respirology COPD Assembly
Journal
Respirology
Year
2025
Materials & Methods
2.1 Literature Search and Review A comprehensive literature search was conducted on the PubMed databases to identify relevant studies based on the objectives of the review. The review attempts to: Review the recent evidence in Asia on the following topics: COPD hospitalisation and mortality burden in Asia. The impact of COPD exacerbation beyond the lung. The effect of cardiopulmonary events following an episode of COPD exacerbation. Other compelling issues that are unique to the Asian region. Key implications due to CVD for clinical practice of COPD in Asia. Provide recommendations to proactively prevent COPD exacerbations and reduce mortality in Asia. The search terms used included COPD-related terms, cardiovascular (CV) disease-related terms, Asia Pacific, Southeast Asia, Asia and specific Asian countries (Bangladesh, China, India, Indonesia, Japan, Malaysia, Pakistan, Singapore, South Korea, Taiwan, Thailand, and Vietnam). The search was restricted to studies conducted in human populations and the English language; however, no time period restriction was applied. Detailed search terms and the iterations used are summarised in the Supporting Information. 2.2 Participants The key members of the COPD Assembly (n = 14), including the leadership troika (Head, Head-Elect, and Deputy Head) and cardiologists (n = 3) from Hong Kong, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam collaborated over a series of virtual monthly meetings between April and October 2024 to define the topics for the project, identify and review existing literature, develop recommendations and write, review, and approve the manuscript.
Conclusion
Asian COPD patients demonstrate distinct risk factors and patterns of disease. The demographic characteristics, socioeconomic status, and healthcare systems in the region are also diverse and differ from those in Western countries. Considering the unique features of the population and the challenges faced by physicians in the region, a tailored approach is desirable for the optimum management of patients with concomitant COPD and CVD.
Resources and Links
Phone Number: +603 2781 4519 / +603 2781 4520
https://onlinelibrary.wiley.com/doi/10.1111/resp.70103
Share the Page
|
Information
Consultant Name
Dr Helmy Haja Mydin
For general questions about clinical trials
Phone Number: +603 2781 4519 / +603 2781 4520
Clinical trials are part of research studies involving patient volunteers that are conducted to find safe and effective treatments for a variety of health conditions. They are critical to the advancement of medicine and improving patient health. Participating in clinical trials offers patients the opportunity to try new and effective treatments that could potentially improve their condition while taking part in vital research that can benefit many future patients.
In Pantai Hospital Kuala Lumpur, clinical trials are carried out under our Clinical Research team.
If you would like to participate in any of our clinical trials or would like to know, please provide your information below and we will be in touch with you:
8, Jalan Bukit Pantai, 59100 Kuala Lumpur, Malaysia
.png?sfvrsn=71934c60_8)
.png?sfvrsn=1370dfbd_9)
